Long-term exposure to [Cr3O(O2CCH2CH 3)6(H2O)3]+ in Wistar rats fed normal or high-fat diets does not alter glucose metabolism

Biological Trace Element Research

Volumn 151, Issue 3, 2013, Pages 406-414

  Herring, Betty J ^a   Logsdon, Amanda L ^a   Lockard, Jarrett E ^a   Miller, Brittany M ^a   Kim, Hanna ^a   Calderon, Eric A ^a   Vincent, John B ^b   Bailey, Melissa M ^a  

^a EMPORIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA   (United States)

Author keywords

Cafeteria diet; Cr3; Glucose; Rat

Indexed keywords

CHROMIUM DERIVATIVE; GLUCOSE; INSULIN; INSULIN ZINC SUSPENSION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BODY MASS; CARBOHYDRATE DIET; CLINICAL EVALUATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID DIET; LONG TERM CARE; LONG TERM EXPOSURE; NONHUMAN; NUTRITIONAL ASSESSMENT; RAT; THERAPY EFFECT; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS; RODENTIA;

ANIMALS; DIET; DIETARY FATS; GLUCOSE; MALE; ORGANOMETALLIC COMPOUNDS; RATS; RATS, WISTAR; TIME FACTORS;

EID: 84885290884     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-012-9580-9     Document Type: Article

References (38)

1. Schwarz K, Mertz W (1957) A glucose tolerance factor and its differentiation from factor 3. Arch Biochem Biophys 72:515-518
2. Schwarz K, Mertz W (1959) Chromium(III) and the glucose tolerance factor. Arch Biochem Biophys 292-295
3. Stearns DM (2000) Is chromium a trace essential metal? BioFactors 11:149-162
4. Vincent JB (2001) The bioinorganic chemistry of chromium(III). Polyhedron 20:1-26
5. Trumbo P, Yates AA, Schlicker S et al (2001) Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc 101:294-301
6. Di Bona KR, Love S, Rhodes NR et al (2011) Chromium is not an essential trace element for mammals: effects of a "low-chromium" diet. J Biol Inorg Chem 16:381-390
7. Cefalu WT, Wang ZQ, Zhang LC et al (2002) Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr 132:1107-1114
8. Striffler JS, Law JS, Polansky MM et al (1995) Chromium improves insulin response to glucose in rats. Metabolism 44:1314-1320
9. Striffler JS, Polansky MM, Anderson RA (1999) Overproduction of insulin in the chromium deficient rat. Metabolism 47:1063-1068
10. Striffler JS, Polansky MM, Anderson RA (1998) Dietary chromium decreases insulin resistance in rats fed a high fat mineral imbalances diet. Metabolism 47:396-400
11. Lara PM, Vincent JB (2009) Tracing the fate of chromium nutritional supplements in the body. J Sci Health Univ AL 6:21-26
12. Rhodes NR, McAdory D, Love S et al (2010) Urinary chromium loss associated with diabetes is offset by increases in absorption. J Inorg Biochem 104:790-797
13. Nielsen FH (1996) Controversial chromium: does the superstar mineral of the mountebanks receive appropriate attention from clinicians and nutritionists? Nutr Today 31:226-233
14. Althuis MD, Jordan NE, Ludington EA et al (2002) Glucose and insulin responses to dietary chromium supplements: a metaanalysis. Am J Clin Nutr 76:148-155
15. Vincent JB (2003) The potential value and potential toxicity of chromium picolinate as a nutritional supplement, weight loss agent, and muscle development agent. Sports Med 33:213-230
16. Lefavi RG, Anderson RA, Keith RE et al (1992) Efficacy of chromium supplementation in athletes: emphasis on anabolism. Int J Sports Med 2:111-122
17. Balk EM, Tatsioni A, Lichtenstein AH et al (2007) Effect of chromium supplementation on glucose metabolism and lipids. Diabetes Care 30:2154-2162
18. Anderson RA, Kozlovsky AS (1985) Chromium intake, absorption, and excretion of subjects consuming self-selected diets. Am J Clin Nutr 41:1177-1183
19. Król E, Krejpcio Z (2010) Chromium(III) propionate complex supplementation improves carbohydrate metabolism in insulinresistance rat model. Food Chem Toxicol 48:2791-2796
20. Sundaram B, Singhal K, Sandhir R (2012) Ameliorating effect of chromium administration on hepatic glucose metabolism in streptozotocin-induced experimental diabetes. BioFactors 38:59-68
21. Lai M, Chen Y, Cheng H (2006) Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin-induced diabetic rats. Int J Vitam Nutr Res 76:391-397
22. Xia W-S, Radosevich J, Ellern A (2006) Triaqua-μ3-oxo-hexa-μ2- propionato-κ12O:O-trichromium(III) nitrate hemihydrates. Acta Crystallogr E62:m1213-m1215
23. Vincent JB (2013) The bioinorganic chemistry of chromium(III). Wiley, Chichester
24. Spears JW, Whisnant GS, Huntington GB et al (2012) Chromium propionate enhances insulin sensitivity in growing cattle. J Dairy Sci 95:2037-2045
25. Clodfelder BJ, Chang C, Vincent JB (2004) Absorption of the biomimetic chromium cation triaqua-μ3-oxo-μ-hexapropionatotrichromium (III) in rats. Biol Trace Elem Res 97:1-11
26. Holemans K, Caluwaerts S, Poston L et al (2004) Diet-induced obesity in the rat: a model for gestational diabetes mellitus. Am J Obstet Gynecol 190:858-865
27. Earnshaw A, Figgis BN, Lewis J (1966) Chemistry of polynuclear compounds: Part IV. Magnetic properties of trimeric chromium and iron compounds. J Chem Soc (A):1656-1663
28. van den Bergen AR, Colton R, Percy M et al (1993) Electrospray mass spectrometric study of [M3O(RCOO)6L3]+ cations (M=chromium, iron; L=H2O, MeOH, py). Inorg Chem 32:3408-3411
29. Chakov NE, Collins RA, Vincent JB (1999) A re-investigation of the electronic spectra of chromium(III) picolinate complexes and high yield synthesis and characterization of Cr2(m-OH)2(pic)4&z.ast;5H2O (Hpic = picolinic acid). Polyhedron 18:2891-2897
30. Sun Y, Mallya K, Ramirez J, Vincent JB (1999) The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma cholesterol and triglycerides in rats: towards chromium-containing therapeutics. J Biol Inorg Chem 4:838-845
31. Sun Y, Clodfelder BJ, Shute AA, Irwin T, Vincent JB (2002) The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats. J Inorg Biochem 7:852-862
32. Clodfelder BJ, Gullick BM, Lukaski HC et al (2005) Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats. J Biol Inorg Chem 10:119-130
33. Debski B, Krejpcio Z, Kuryl T et al (2004) Biomimetic chromium (III) complex and fructan supplementation affect insulin and membrane glucose transport in rats. J Trace Elem Exp Med 17:206-207
34. Kuryl T, Krejpcio Z, Wokciak R et al (2006) Chromium(III) propionate and dietary fructans supplementation stimulate glucose uptake and beta-oxidation in lymphocytes of rats. Biol Trace Elem Res 114:237-248
35. Krejpcio Z, Debski B,Wojciak R et al (2004) Biomimetic chromium (III) complex and fructan supplementation improve blood variables in STZ-induced diabetic rats. J Trace Elem Exp Med 17:207-208
36. Król E, Krejpcio Z (2011) Evaluation of anti-diabetic potential of chromium(III) propionate complex in high-fat fed and STZ injected rats. Food Chem Toxicol 49:3217-3223
37. Kleefstra N, Houweling ST, Bakker SJL et al (2007) Chromium treatment has no effect in patients with type 2 diabetes in aWestern population. Diabetes Care 30:1092-1096
38. Iqbal N, Cardillo S, Volger S et al (2009) Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults. Metab Syndr Relat Disord 7:143-150